Abstract
Among the known non-benzodiazepinic hypnotic drugs acting on the α1 subunit of the GABA-A receptor, Zolpidem (2a), Zaleplon (1b) and Indiplon (1a) have showed high affinity and selectivity. Following a design methodology including pharmacophoric requirements and ADME-predicted properties, we have synthesized a library of 3-amino-4,5-dihydro-1H-pyrazolo[3,4-b]pyridin-6(7H)- ones (3) and their N1-alkyl derivatives (4) as new scaffolds for designing non-benzodiazepine BZ receptor ligands.
Original language | English |
---|---|
Pages (from-to) | 1179-1187 |
Number of pages | 9 |
Journal | European Journal of Medicinal Chemistry |
Volume | 40 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 2005 |
Keywords
- ADME
- Catalyst
- Combinatorial chemistry
- GABA-A receptor
- Indiplon
- Non-benzodiazepinic
- Pyrazolo[3,4-b]pyridin-6-ones
- Volsurf
- Zaleplon
- Zolpidem